---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-017297"
form_type: "8-K"
ticker: "MGTX"
cik: "0001735438"
company_name: "MeiraGTx Holdings plc"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T23:14:37.046497+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MeiraGTx reports Q3 2022 net loss $37.3M; receives $25M investment from JJDC

## Summary
- Net loss of $37.3M ($0.83 per share) vs $25.9M ($0.59) in Q3 2021.
- License revenue of $4.8M, down from $6.9M YoY on lower amortization from Janssen.
- Cash and equivalents $114.7M at Sept 30 plus $23.7M receivables from Janssen; funded into Q4 2024.
- Received $25M private placement from JJDC at $6.68/share (3.74M shares) for preclinical and manufacturing.
- Dosing Phase 1 AAV-GAD for Parkinson's; XLRP Phase 3 LUMEOS on track for BLA in 2024.

## SEC filing metadata
- accession: 0001558370-22-017297
- form_type: 8-K
- ticker: MGTX
- cik: 0001735438
- company_name: MeiraGTx Holdings plc
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/0001558370-22-017297-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/mgtx-20221109x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-017297
- JSON: https://secwatch.observer/filing/0001558370-22-017297.json
- Plain text: https://secwatch.observer/filing/0001558370-22-017297.txt

## Key facts
- Earnings Releases
  MeiraGTx Holdings plc reported financial results for third quarter ended September 30, 2022.
  - Period: third quarter ended September 30, 2022
  - Result: reported results
  source text: On November 10, 2022, the Company issued a press release announcing its financial results for the quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/0001558370-22-017297-index.htm
- Material Agreements
  MeiraGTx Holdings plc entered into Securities Purchase Agreement with Johnson and Johnson Innovation – JJDC, Inc. valued at approximately $25.0 million (effective 2022-11-09).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Johnson and Johnson Innovation – JJDC, Inc.
  - Value: approximately $25.0 million
  - Effective: 2022-11-09
  source text: On November 9, 2022, MeiraGTx Holdings plc (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Johnson and Johnson Innovation – JJDC, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/0001558370-22-017297-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.